Please enable JS

Finding clinics

Toxin Consumer Market Study

A consumer market study conducted on “Consumer Experience with Toxin Resistance” across 7 Asia Pacific countries (Australia, Hong Kong, India, Singapore, South Korea, Taiwan and Thailand) and included 2,201 Botulinum toxin users who have taken at least 3 treatments, from the ages of 21 to 55 years old. There are 72% of Hong Kong respondents experienced a decline in treatment effects.*

75
Of Hong Kong users who have taken at least 3 treatments, have experienced a decline in treatment effects.#
68
Of Hong Kong users continued their Botulinum Toxin A treatments despite experiencing decreasing efficacy in their treatments.#
70
Of Hong Kong users are not aware that the presence of impurities* such as complexing proteins, may lead to antibody formation against Botulinum Toxin within our body#^

# A consumer market study conducted on “Consumer Experience with Toxin Resistance” by Frost & Sullivan across 7 Asia Pacific Countries (Australia, Hong Kong, India, Singapore, South Korea, Taiwan and Thailand) and included 2,201 Botulinum toxin users from the ages of 21 to 55 years old.

^ Excluded the patients who experienced the Boutulinum Toxin A treatment which as presence of impurities*

* Impurities refer to the presence of complexing proteins, inactive neurotoxin, flagellin and bacterial DNA contaminants.1

1 Park JY, et al. Neurotoxin impurities: A Review of threats to Efficacy. Plast Recontr Surg Glob Open. 2020;8(1):e2627

Toxin Consumer Market Study

The Pure Toxin Xeomin with Zero impurities*(No complexing proteins), let’s get your beauty journey started.

Learn More

Understand the New Generation Botulinum Toxin

XEOMIN®(incobotulinumtoxinA) is a new generation, pure botulinum toxin, free from impurities*

Learn More

Ask the Expert

Learn about the experts say about XEOMIN® (incobotulinumtoxinA).

Learn More

XEOMIN®– THE PURE TOXIN

XEOMIN® is approved by the US Food and Drug Administration (US FDA), UK MHRA, The Federal Institute for Drugs and Medical Devices in Germany and the Hong Kong Department of Health. A state-of-the-art purification process removes the unnecessary impurities*, providing only the purified active neurotoxin for treatment, with lower risk of antibody formation.

ZERO IMPURITIES*

Introducing the pure toxin with zero impurities* and zero complexing proteins is a new generation highly purified Botulinum Toxin. It provides the full benefits of Botulinum Toxin with lower risk of antibody formation that may cause toxin resistance during treatment.

CHOOSE SAFETY

For all the benefits you can experience with Botulinum Toxin treatments, choose the Pure Toxin with Zero Impurities* as your lifetime aesthetic treatment that gives you natural and lasting results you desire.

Results within 2-3 days2

More than 98% of users are satisfied with XEOMIN® treatment results.3

Impurities refer to the presence of complexing proteins, inactive neurotoxin, flagellin and bacterial DNA contaminants.1

Reference:

1. Park JY, et al. Neurotoxin impurities: A Review of threats to Efficacy. Plast Recontr Surg Glob Open. 2020;8(1):e2627

2. Prager W et al. Onset, longevity, and patient satisfaction with incobotulinumtoinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study.

3. Imhof M, et al. A Phase III Study of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines. J Clin Aesthest Dermatol. 2011;4(10):28-34.

Ask the Expert

DR. KATE GOLDIE
Aesthetic Physician, UK
Dr. Goldie has been an aesthetic physician for 10 years and is the Medical Director of European Medical Aesthetics training, one of European largest training companies. Through Medics Direct, the UK training arm of this organization she has overseen the training of over 4000 medical professionals.
了解更多
DR. JÜRGEN FREVERT
PhD, Biochemist
Dr Jürgen Frevert could be described as the father of XEOMIN®. He first heard of the toxin more than 30 years ago, when, as a post-doctoral researcher, he was tasked with purifying botulinum toxin type A.
了解更多
DR. MICHAEL PFEIL
PhD, Site Head of Merz Pharmaceuticals’ state-of-the-art production facility at Dessau, Germany
Michael Pfeil has been involved in the manufacture of XEOMIN® from day 1.
了解更多
DR. MED. T. WALKER
Dermatologist
German dermatologist Dr. Med. T. Walker has been using XEOMIN®clinically for more than a decade. With his wealth of experience, he explains in detail the medical cosmetic trends in Germany and Europe and the widespread use of botulinum toxin Fallacies, as well as the benefits of home-use type A pure botulinum toxin without complex proteins.
了解更多
DR. TATJANA PAVICIC
Dermatologist
Based on years of clinical experience, Dr Tatjana Pavicic, board member of the International Society for Derm Surgery, also explains how to properly use Type A botulinum toxin to reduce wrinkles and improve skin aging by analyzing facial dynamic and static patterns.
了解更多